Digoxin and Basal cell carcinoma - a phase IV clinical study of FDA data
Summary:
We study 90,380 people who have side effects when taking Digoxin. Basal cell carcinoma is found, especially among people who are male, 60+ old, have been taking the drug for 10+ years, also take Prednisone and have Osteoporosis.
The phase IV clinical study analyzes which people take Digoxin and have Basal cell carcinoma. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
90,380 people reported to have side effects when taking Digoxin.
Among them, 137 people (0.15%) have Basal cell carcinoma.
What is Digoxin?
Digoxin has active ingredients of digoxin. It is used in atrial fibrillation/flutter. Currently, eHealthMe is studying from 91,815 Digoxin users.
What is Basal cell carcinoma?
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills) is found to be associated with 2,086 drugs and 1,288 conditions by eHealthMe. Currently, we are studying 25,551 people who have Basal cell carcinoma.
Number of Digoxin and Basal cell carcinoma reports submitted per year:
Time on Digoxin when people have Basal cell carcinoma *:
Gender of people who have Basal cell carcinoma when taking Digoxin*:
Age of people who have Basal cell carcinoma when taking Digoxin *:
Common drugs people take besides Digoxin *:
Common side effects people have besides Basal cell carcinoma *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Digoxin and have Basal cell carcinoma?
Check whether Basal cell carcinoma is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
Related studies
Digoxin side effects by duration, gender and age:
- Digoxin side effects (91,815 reports)
Basal cell carcinoma treatments and more:
- Basal cell carcinoma (25,551 reports)
Common drugs associated with Basal cell carcinoma:
- Methotrexate: 2,855 reports
- Remicade: 2,468 reports
- Prednisone: 2,427 reports
- Humira: 2,191 reports
- Enbrel: 1,647 reports
- Aspirin: 1,395 reports
- Fosamax: 1,334 reports
- Orencia: 1,171 reports
- Xeljanz: 1,040 reports
- Codeine: 1,027 reports
All the drugs that are associated with Basal cell carcinoma:
- Basal cell carcinoma (2,086 drugs)
Common conditions associated with Basal cell carcinoma:
- Rheumatoid arthritis: 3,325 reports
- Psoriasis: 1,484 reports
- Multiple sclerosis: 1,271 reports
- High blood pressure: 1,259 reports
- Multiple myeloma: 952 reports
- Crohn's disease: 921 reports
- Osteoporosis: 897 reports
All the conditions that are associated with Basal cell carcinoma:
- Basal cell carcinoma (1,288 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on digoxin (the active ingredients of Digoxin) and Digoxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Valium and Vaginal Infection - now
- Norvasc and Incision Site Haemorrhage - now
- Allopurinol and Robitussin drug interaction - 2 seconds ago
- Lumigan and Betoptic drug interaction - 6 seconds ago
- Gaviscon and Therapeutic Response Unexpected - 12 seconds ago
- Librium and Zubsolv drug interaction - 22 seconds ago
- Darzalex and Confusional State - 23 seconds ago
- Vitamin C and Capoten drug interaction - 25 seconds ago
- Glimepiride and Oxycodone And Acetaminophen drug interaction - 34 seconds ago
- Vagifem and Montelukast Sodium drug interaction - 34 seconds ago